Stem cell factor expression in B cell malignancies is influenced by the niche

Leukemia and Lymphoma

Volumn 54, Issue 10, 2013, Pages 2274-2280

  Fox, Matthew F ^a   Pontier, Andrea ^a   Gurbuxani, Sandeep ^a   Sipkins, Dorothy A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

B cell malignancies; Leukemia; Lymphoma; Niche; Stem cell factor

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; STEM CELL FACTOR; TRANSCRIPTION FACTOR PAX5;

ADULT; ARTICLE; B CELL LYMPHOMA; BONE MARROW; BURKITT LYMPHOMA; CELL INTERACTION; CHRONIC LYMPHATIC LEUKEMIA; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE; LYMPHOCYTOMA; LYMPHOMA CELL; MALIGNANT TRANSFORMATION; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL NICHE; TUMOR MICROENVIRONMENT; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; BIOPSY; BONE MARROW; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, B-CELL; LYMPH NODES; LYMPHOMA, B-CELL; STEM CELL FACTOR; STEM CELL NICHE;

EID: 84884498262     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.777067     Document Type: Article

References (27)

1. Broudy VC. Stem cell factor and hematopoiesis. Blood 1997; 90: 1345-1364.
2. Driessen RL, Johnston HM, Nilsson SK. Membrane-bound stem cell factor is a key regulator in the initial lodgment of stem cells within the endosteal marrow region. Exp Hematol 2003; 31: 1284-1291.
3. Heinrich MC, Dooley DC, Freed AC, et al. Constitutive expression of steel factor gene by human stromal cells. Blood 1993; 82: 771-783.
4. Lammie A, Drobnjak M, Gerald W, et al. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem 1994; 42: 1417-1425.
5. Ashman LK. The biology of stem cell factor and its receptor c-kit. Int J Biochem Cell Biol 1999; 31: 1037-1051.
6. Sharma S, Gurudutta GU, Satija NK, et al. Stem cell c-KIT and HOXB4 genes: Critical roles and mechanisms in self-renewal, proliferation, and differentiation. Stem Cells Dev 2006; 15: 755-778.
7. McCulloch EA, Siminovitch L, Till JE, et al. The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl/Sld. Blood 1965; 26: 399-410.
8. Kapur R, Majumdar JK, Xiao X, et al. Transgenic expression of stem cell factor in Steel-Dickie mice: Delineation of a unique in vivo role of membrane-associated protein in erythropoiesis. Blood 1996; 88(Suppl. 1): 473a.
9. Rodewald H -R, K retzschmar K, Swat W, et al. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 1995; 3: 313-319.
10. Landreth KS, Kincade PW, Lee G, et al. Blymphocyte precursors in embryonic and adult W anemic mice. J Immunol 1984; 132: 2724-2729.
11. Palacios R, Nishikawa S. Developmentally regulated cell surface expression and function of c-kit receptor during lymphocyte ontogeny in the embryo and adult mice. Development 1992; 115: 1133-1144.
12. Sperling C, Schwartz S, Buchner T, et al. Expression of the stem cell factor receptor c-kit (CD117) in acute leukemias. Haematologica 1997; 82: 617-621.
13. Legitimo A, Consolini R, Cocito MG, et al. The c-kit receptor and its ligand stem cell factor in childhood malignant lymphoid precursors. J Interferon Cytokine Res 1999; 19: 981-987.
14. Pinto A, Gloghini A, Gattei V, et al. Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30 + anaplastic large cell lymphomas. Blood 1994; 83: 785-792.
15. Carlesso N, Pregno P, Bresso P, et al. Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. Leukemia 1992; 6: 642-648.
16. Giehl KA, Nagele U, Volkenandt M, et al. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma. J Cutan Pathol 2007; 34: 7-14.
17. Ulivi P, Zoli W, Medri L, et al. c-kit and SCF expression in normal and tumor breast tissue. Breast Cancer Res Treat 2004; 83: 33-42.
18. Yasuda A, Sawai H, Takahashi H, et al. Stem cell factor/c-kit receptor signaling enhances the proliferation and invasion of colorectal cancer cells through the PI3K/Akt pathway. Dig Dis Sci 2007; 52: 2292-2300.
19. Zhang W, Stoica G, Tasca SI, et al. Modulation of tumor angiogenesis by stem cell factor. Cancer Res 2000; 60: 6757-6762.
20. Colmone A, Amorim M, Pontier AL, et al. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 2008; 322: 1861-1865.
21. ArgatoffLH, Connors JM, Klasa RJ, et al. Mantle cell lymphoma: A clinicopathologic study of 80 cases. Blood 1997; 89: 2067-2078.
22. Han Z-B, Ren H, Zhao H, et al. Hypoxia-inducible factor (HIF)- 1alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 2008; 29: 1853-1861.
23. Kassel O, Schmidlin F, Duvernelle C, et al. Up- and downregulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture. Mol Pharmacol 1998; 54: 1073-1079.
24. Da Silva CA, Heilbock C, Kassel O, et al. Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin- 1beta through concerted regulation of a GRE-like and an NF-kappaB response element. FASEB J 2003; 17: 2334-2336.
25. Sun L, Hui A-M, Su Q, et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006; 9: 287-300.
26. Farinha P, Kyle AH, Minchinton AI, et al. Vascularization predicts overall survival and risk of transformation in follicular lymphoma. Haematologica 2010; 95: 2157-2160.
27. Ghielmini M, Schmitz S-FH, Cogliatti SB, et al. Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule. Blood 2004; 103: 4416-4423.